A significant breakthrough in cancer investigation is arising with the use of VHH fragments to re-engage mutated p53. This crucial malignant inhibitor protein is frequently inactivated in various types of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research